Poster Session 3: Day 2 - Wed 24 Sep, 10.30 am to 11.00 am |
POSTER ID | TITLE | PRESENTING AUTHOR |
P72 | Non-comparable patients in non-randomised comparative studies: misleading study design? | SOHAN DESHPANDE |
P73 | Meta-analysis of continuous outcomes: systematic review of methods available for dealing with missing mean and standard deviation values | Isabella Butcher |
P75 | Reporting of perinatal mortality and its components in Cochrane reviews: still room for improvement? | Emily Bain |
P76 | A typology of questions for systematic reviews on complex interventions | Karin Hannes |
P77 | Challenges in conducting economic evaluation informed by Cochrane Reviews: case study of adherence in epilepsy | Catrin Plumpton |
P78 | Update of the Cochrane systematic review of interventions for preventing obesity in children: a research program | Elizabeth Waters |
P79 | Challenges and considerations involved in using AMSTAR in overviews of reviews | Michelle Foisy |
P80 | The benefits and harms of methylphenidate treatment for attention deficit hyperactivity disorder (ADHD) in children and adolescents: preliminary results | Ole Jakob Storebø |
P82 | Should Cochranites adopt a specific hierarchy of outcomes? | Ciprian Jauca |
P83 | Lack of originality in non-Cochrane systematic reviews | Nicole Fusco |
P84 | Systematic reviews of risk factors: methodological challenges and implications for evidence reviewers | Hans Van Remoortel |
P85 | Characteristics of cross-over trials in dentistry and oral health reviews | Sumanth Kumbargere Nagraj |
P86 | Faster may not be better: data abstraction for systematic reviews | Gillian Gresham |
P87 | Meta-analyzing surveillance studies to estimate the burden of vaccine-preventable infectious disease | Kiran Kumar Thumburu |
P88 | How handling of missing data impacts trial results: a meta-epidemiological study | Robin Christensen |
P89 | Instant overviews, and beyond: the case for standardizing reporting in the characteristics of included studies tables | Caroline Struthers |
P90 | How to appraise Individual Participant Data (IPD) meta-analysis in diagnostic and prognostic risk prediction research | Karel Moons |
P91 | Database of appraised studies on patients’ values and preferences | Pablo Alonso |
P92 | Malaysian authors’ perception on the degree of consensus in Cochrane Review development: a preliminary survey | Nai Ming Lai |
P93 | Scoping review for informing and refining the question of a complex Cochrane review | Anel Schoonees |
P95 | Assessing the quality of surveillance studies | Nishant Jaiswal |
P96 | A new candidate TB vaccine: systematic review of animal studies | Rufaro Kashangura |
P97 | Are 'Risk of bias' summary graphs in Cochrane Reviews overestimating bias? | Erik VonElm |
P98 | Informing the methods for public health overview reviews: a descriptive analysis of Cochrane and non-Cochrane public health overviews | Philip Baker |
P99 | Grading the quality of evidence in existing systematic reviews: challenges and considerations | Michelle Foisy |
P100 | A tool to measure complexity in public health interventions | Ravishankar N |
P101 | How do systematic review users and producers interpret the stability of review findings based on GRADE quality of evidence ratings? | Kylie Thaler |
P102 | New recommendations for the 'Implications for research' section of Cochrane reviews | Gustavo Porfirio |
P103 | What to do if the results of conventional pairwise meta-analysis and network meta-analysis are contradictory? An example from a systematic review on the effects of antipsychotics in treatment-resistant schizophrenia | Stefan Leucht |
P105 | Update of the Cochrane systematic review of interventions for preventing obesity in children: overview of systematic reviews | Elizabeth Waters |
P106 | Assessing adverse effects of interventions in Cochrane reviews: what types of study designs are used? | Maíra Parra |
P107 | Cluster randomised trials: a study to help recommendations for better reporting in Cochrane reviews | Marty Richardson |
P109 | Handling missing data in a randomized controlled trial: example from an Attention Deficit/Hyperactive Disorder (ADHD) trial | May Loong Tan |